ARCHIVES

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 40 | October 20, 1995

Download PDF Visit The Full Archive

Related Articles

$1 Million Gift to Duke Funds Urologic Research Center.

November 24, 2000

Senate Report Calls on NCI To Expand Research in Survivorship, CAM, GYN Cancers, And Fund Five Pancreatic SPOREs

August 2, 2002

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

November 27, 1998

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

July 28, 1995

Lederle Scientists Report Powerful New Anticancer Agent

July 31, 1987

DeVita, Seffrin Present Cancer Czar PlanTo Feinstein, Without Committee Sign-Off

June 1, 2001